Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $108.26 USD
Change Today +0.48 / 0.45%
Volume 342.6K
LGND On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Frankfurt
OTC US
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bert W. O'Malley Jr., M.D.

Former Member of Scientific Advisory Board, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 75 board members in 1 different organizations across 4 different industries.

See Board Relationships
77--

Background*

Dr. Bert W. O'Malley, Jr., MD., serves as the Editor-in Chief of the ORL, Journal of Oto-Rhino-Laryngology. Dr. O'Malley serves as Tom Thompson Distinguished Service Professor of the Department of Cell Biology at Baylor College of Medicine. Dr. O'Malley Co-founded GeneMedicine, Inc. Dr. O'Malley serves as Co-Director, Head and Neck Cancer Center. He is a Gabriel Tucker Professor of Otorhinolaryngology at University of Pennsylvania Health System Philadelphia, Pennsylvania. ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of Pittsburgh
MD
University of Pittsburgh
Honorary Doctorate
Karolinska Institutet
Honorary Doctorate
New York Medical College
MD
University of Texas Southwestern Medical Center - Dallas

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $108.26 USD +0.48

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.